A treatment for fibromatosis is provided and, particularly, a treatment for palmar and/or plantar fascial fibromatosis is provided. The administration of a plasminogen activator locally to the affected tissue has been found to greatly improve the range of motion to the affected region, to reduce the appearance of the formed cords and nodules and to facilitate easier removal of these structures, if required.
